Tenascin-C Expression Correlates with Prognosis in Gastric Cancer

Abstract

Objectives: Tenascin-C is a hexameric extracellular matrix glycoprotein that is expressed during embryonic development and re-expressed in proliferative processes such as wound healing and tumorigenesis. Stromal tenascin-C may block tumor invasion and thus have a significant influence on tumor spread and prognosis. Methods: In the present study, tissue expression of stromal tenascin-C was studied by immunohistochemistry in a series of 314 patients with gastric cancer. Results: Strong tenascin-C positivity was seen in the stroma of the tumor in 122 (39%) cases. There was a correlation between strong tenascin-C expression and low stage (p = 0.002), superficial tumor penetration (p = 0.02), location of tumor at the distal third of the stomach (p = 0.03), and potentially curative surgery (p = 0.008). No significant correlation was found between tenascin-C positivity and nodal status, distant metastases, age, Laurén classification, gender, tumor size, or Borrmann classification. The cumulative 5-year survival in patients with strong tenascin-C expression was 42% compared to 26% in those with negative-to-moderate expression (p = 0.0053). In multivariate survival analysis stratified for estimated cure of surgery, stage of disease was the only independent prognostic factor. Conclusion: In conclusion, tenascin-C expression seems to correlate with cancer related survival in patients with gastric cancer, but may not add significant prognostic information to that provided by TNM stage.

Bikunin Target Genes in Ovarian Cancer Cells Identified by Microarray Analysis

“…Two genes encode a voltage-independent calcium-activated channel and a voltage-dependent chloride channel (29) were also repressed. Syndecan has a role in cell adhesion, maturation, proliferation, and prognosis (30). PAPP-A is the insulin-like growth factor-binding protein protease (31).…”

In Vivo and in Vitro Regulation of Syndecan 1 in Prostate Cells by n-3 Polyunsaturated Fatty Acids

“…In studies of various cancers, loss of SDC-1 expression has been associated with tumor progression and aggressiveness (7)(8)(9)(10)(11)(12)(13). In contrast, an elevation in SDC-1 expression in stromal cells was associated with tumor progression (14) and poor clinical outcome (15)(16)(17). In human prostate cancer, there are conflicting data.…”

Prognostic and predictive markers in canine tumours: Rationale and relevance. A review

“…Tenascin-C, a large ECM glycoprotein, is implicated in cell adhesion and proliferation, and its overproduction is associated with poor prognosis in several human tumours including colorectal (46), breast (36) and gastric (111) cancer. In canine tumours, no studies have been done on the prognostic significance of tenascin-C.…”